| |
| |
|
| Insider
Information: |
Emmens Matthew |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
201,133 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$95,444,436 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
201,133 |
|
|
| Total
Value |
$95,444,436 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2012-11-16 |
200,873 |
2009-02-05 |
0 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Director |
2017-02-21 |
260 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2017-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
260 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
President |
• • – |
2009-02-05 |
4 |
A |
$0.01 |
$1,341 |
D/D |
134,129 |
134,129 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
President & CEO |
• • – |
2010-02-04 |
4 |
A |
$0.01 |
$472 |
D/D |
47,201 |
182,205 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
President & CEO |
• • – |
2011-02-03 |
4 |
A |
$0.01 |
$472 |
D/D |
47,201 |
229,406 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• – – |
2011-02-06 |
4 |
AS |
$36.39 |
$2,115,742 |
D/D |
(56,000) |
211,601 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• – – |
2011-05-25 |
4 |
S |
$55.51 |
$540,390 |
D/D |
(9,735) |
220,400 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-11-16 |
4 |
S |
$41.76 |
$453,096 |
D/D |
(10,850) |
200,873 |
0 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
